Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model

The coronavirus disease 2019 (COVID-19) pandemic continues to cause significant morbidity and mortality worldwide. Since a large portion of the world’s population is currently unvaccinated or incompletely vaccinated and has limited access to approved treatments against COVID-19, there is an urgent n...

Descripción completa

Detalles Bibliográficos
Autores principales: Péricat, David, Leon-Icaza, Stephen Adonai, Sanchez Rico, Marina, Mühle, Christiane, Zoicas, Iulia, Schumacher, Fabian, Planès, Rémi, Mazars, Raoul, Gros, Germain, Carpinteiro, Alexander, Becker, Katrin Anne, Izopet, Jacques, Strub-Wourgaft, Nathalie, Sjö, Peter, Neyrolles, Olivier, Kleuser, Burkhard, Limosin, Frédéric, Gulbins, Erich, Kornhuber, Johannes, Meunier, Etienne, Hoertel, Nicolas, Cougoule, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657171/
https://www.ncbi.nlm.nih.gov/pubmed/36362409
http://dx.doi.org/10.3390/ijms232113623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657171/
https://www.ncbi.nlm.nih.gov/pubmed/36362409
http://dx.doi.org/10.3390/ijms232113623

Ejemplares similares